Adalimumab in rheumatoid arthritis after failed infliximab and/or etanercept therapy: experience with 18 patients

被引：17

作者：

Brocq, O ^{[1
]}

Albert, C ^{[1
]}

Roux, C ^{[1
]}

Gerard, D ^{[1
]}

Breuil, V ^{[1
]}

Ziegler, LE ^{[1
]}

机构：

[1] Archet 1 Teaching Hosp, Dept Rheumatol, F-06202 Nice 3, France

来源：

JOINT BONE SPINE | 2004年 / 71卷 / 06期

关键词：

rheumatoid arthritis; TNF alpha; treatment;

D O I：

10.1016/j.jbspin.2004.07.009

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：601 / 603

页数：3

共 10 条

[1] THE AMERICAN-RHEUMATISM-ASSOCIATION 1987 REVISED CRITERIA FOR THE CLASSIFICATION OF RHEUMATOID-ARTHRITIS [J].

ARNETT, FC ;

EDWORTHY, SM ;

BLOCH, DA ;

MCSHANE, DJ ;

FRIES, JF ;

COOPER, NS ;

HEALEY, LA ;

KAPLAN, SR ;

LIANG, MH ;

LUTHRA, HS ;

MEDSGER, TA ;

MITCHELL, DM ;

NEUSTADT, DH ;

PINALS, RS ;

SCHALLER, JG ;

SHARP, JT ;

WILDER, RL ;

HUNDER, GG .

ARTHRITIS AND RHEUMATISM, 1988, 31 (03) :315-324

[2]

Brocq O, 2002, PRESSE MED, V31, P1836

[3] Switching between anti-TNFα agents:: what is the evidence? [J].

Combe, B .

JOINT BONE SPINE, 2004, 71 (03) :169-171

[4] AMERICAN-COLLEGE-OF-RHEUMATOLOGY PRELIMINARY DEFINITION OF IMPROVEMENT IN RHEUMATOID-ARTHRITIS [J].

FELSON, DT ;

ANDERSON, JJ ;

BOERS, M ;

BOMBARDIER, C ;

FURST, D ;

GOLDSMITH, C ;

KATZ, LM ;

LIGHTFOOT, R ;

PAULUS, H ;

STRAND, V ;

TUGWELL, P ;

WEINBLATT, M ;

WILLIAMS, HJ ;

WOLFE, F ;

KIESZAK, S .

ARTHRITIS AND RHEUMATISM, 1995, 38 (06) :727-735

[5] Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate:: a randomised phase III trial [J].

Maini, R ;

St Clair, EW ;

Breedveld, F ;

Furst, D ;

Kalden, J ;

Weisman, M ;

Smolen, J ;

Emery, P ;

Harriman, G ;

Feldmann, M ;

Lipsky, P .

LANCET, 1999, 354 (9194) :1932-1939

[6] Etanercept therapy in rheumatoid arthritis - A randomized, controlled trial [J].

Moreland, LW ;

Schiff, MH ;

Baumgartner, SW ;

Tindall, EA ;

Fleischmann, RM ;

Bulpitt, KJ ;

Weaver, AL ;

Keystone, EC ;

Furst, DE ;

Mease, PJ ;

Ruderman, EM ;

Horwitz, DA ;

Arkfeld, DG ;

Garrison, L ;

Burge, DJ ;

Blosch, CM ;

Lange, MLM ;

McDonnell, ND ;

Weinblatt, ME .

ANNALS OF INTERNAL MEDICINE, 1999, 130 (06) :478-+

[7] Factors predicting responsiveness to anti-TNFα therapy in patients with rheumatoid arthritis:: using biotherapies rationally [J].

Mugnier, B ;

Roudier, J .

JOINT BONE SPINE, 2004, 71 (02) :91-94

[8]

Shergy W, 2001, ARTHRITIS RHEUM, V44, pS81

[9] Treatment with infliximab (Remicade) when etanercept (Enbrel) has failed or vice versa:: data from the STURE registry showing that switching tumour necrosis factor α blockers can make sense [J].

van Vollenhoven, R ;

Harju, A ;

Brannemark, S ;

Klareskog, L .

ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 (12) :1195-1198

[10] Efficacy, pharmacokinetic, and safety assessment of adalimumab, a fully human anti-tumor necrosis factor-alpha monoclonal antibody, in adults with rheumatoid arthritis receiving concomitant methotrexate: A pilot study [J].

Weisman, MH ;

Moreland, LW ;

Furst, DE ;

Weinblatt, ME ;

Keystone, EC ;

Paulus, HE ;

Teoh, LS ;

Velagapudi, RB ;

Noertersheuser, PA ;

Granneman, GR ;

Fischkoff, SA ;

Chartash, EK .

CLINICAL THERAPEUTICS, 2003, 25 (06) :1700-1721

← 1 →